Zai Lab Ltd (NAS:ZLAB)
$ 20.16 0.15 (0.75%) Market Cap: 1.98 Bil Enterprise Value: 1.42 Bil PE Ratio: 0 PB Ratio: 2.57 GF Score: 71/100

Zai Lab Ltd at Goldman Sachs Global Healthcare Conference (Virtual) Transcript

Jun 08, 2021 / 12:50PM GMT
Release Date Price: $169.07 (-1.29%)
Ziyi Chen
Goldman Sachs Group, Inc., Research Division - Equity Analyst

Thank you. Thank you, everyone, for joining this session at Goldman Sachs Global Healthcare Conference. This is Ziyi Chen, China heath care analyst at Goldman. So this session is for Zai Lab. So today, we are very pleased to have the Head of BD of Zai Lab, Jonathan Wang to join this session to discuss with us the most updated progress in BD and also the overall strategy of the Zai Lab. Thank you, Jonathan, for joining us.

Jonathan J. Wang
Zai Lab Limited - Executive VP & Head of Business Development

Thank you, Ziyi. And thank you, Goldman Sachs. Yes.

Questions & Answers

Ziyi Chen
Goldman Sachs Group, Inc., Research Division - Equity Analyst

Yes. We're going to start with some of the broad questions. I think in the past 6 months, we have seen major progress in the BD side. I think -- thanks to you and your teams great effort on getting all those assets in the past 6 months, we have seen 4 major deals coming in and 4 major assets

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot